Document:

exv4w7

Exhibit 4.7

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE
SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION
STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY
TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM
THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF
SECTION 7 OF THIS WARRANT.

WATERFRONT MEDIA INC.

WARRANT TO PURCHASE SHARES

OF SERIES F PREFERRED STOCK

     THIS CERTIFIES THAT, for value received, COMPASS HORIZON FUNDING COMPANY LLC and its assignees
are entitled to subscribe for and purchase 65,674 shares of the fully paid and nonassessable Series
Preferred Stock (as adjusted pursuant to Section 4 hereof, the “Shares”) of WATERFRONT MEDIA, INC.,
a Delaware corporation (the “Company”), at the price of $7.6134 per share (such price and such
other price as shall result, from time to time, from the adjustments specified in Section 4 hereof
is herein referred to as the “Warrant Price”), subject to the provisions and upon the terms and
conditions hereinafter set forth. As used herein, (a) the term “Series Preferred” shall mean the
Company’s presently authorized Series F Preferred Stock, and any stock into or for which such
Series F Preferred Stock may hereafter be converted or exchanged, and after the automatic
conversion of the Series F Preferred Stock to Common Stock shall mean the Company’s Common Stock,
(b) the term “Date of Grant” shall mean October 8, 2009, and (c) the term “Other Warrants” shall
mean any other warrants issued by the Company in connection with the transaction with respect to
which this Warrant was issued, and any warrant issued upon transfer or partial exercise of or in
lieu of this Warrant. The term “Warrant” as used herein shall be deemed to include Other Warrants
unless the context clearly requires otherwise.

     1. Term. The purchase right represented by this Warrant is exercisable, in whole or
in part, at any time and from time to time from the Date of Grant through the later of (i) ten (10)
years after the Date of Grant or (ii) five (5) years after the closing of the Company’s initial
public offering of its Common Stock (“IPO”) effected pursuant to a Registration Statement on Form
S-1 (or its successor) filed under the Securities Act of 1933, as amended (the “Act”).

     2. Method of Exercise; Payment; Issuance of New Warrant. Subject to Section 1 hereof,
the purchase right represented by this Warrant may be exercised by the holder hereof, in whole or
in part and from time to time, at the election of the holder hereof, by (a) the surrender of this
Warrant (with the notice of exercise substantially in the form attached hereto as Exhibit A-1 duly
completed and executed) at the principal office of the Company and by the payment to the Company,
by certified or bank check, or by wire transfer to an account designated by the

 

 

Company (a “Wire Transfer”) of an amount equal to the then applicable Warrant Price multiplied
by the number of Shares then being purchased; (b) if in connection with a registered public
offering of the Company’s securities, the surrender of this Warrant (with the notice of exercise
form attached hereto as Exhibit A-2 duly completed and executed) at the principal office of the
Company together with notice of arrangements reasonably satisfactory to the Company for payment to
the Company either by certified or bank check or by Wire Transfer from the proceeds of the sale of
shares to be sold by the holder in such public offering of an amount equal to the then applicable
Warrant Price per share multiplied by the number of Shares then being purchased; or (c) exercise of
the “net issuance” right provided for in Section 10.2 hereof. The person or persons in whose
name(s) any certificate(s) representing shares of Series Preferred shall be issuable upon exercise
of this Warrant shall be deemed to have become the holder(s) of record of, and shall be treated for
all purposes as the record holder(s) of, the shares represented thereby (and such shares shall be
deemed to have been issued) immediately prior to the close of business on the date or dates upon
which this Warrant is exercised. In the event of any exercise of the rights represented by this
Warrant, certificates for the shares of stock so purchased shall be delivered to the holder hereof
as soon as possible and in any event within thirty (30) days after such exercise and, unless this
Warrant has been fully exercised or expired, a new Warrant representing the portion of the Shares,
if any, with respect to which this Warrant shall not then have been exercised shall also be issued
to the holder hereof as soon as possible and in any event within such thirty-day period; provided,
however, at such time as the Company is subject to the reporting requirements of the Securities
Exchange Act of 1934, as amended, if requested by the holder of this Warrant, the Company shall
cause its transfer agent to deliver the certificate representing Shares issued upon exercise of
this Warrant to a broker or other person (as directed by the holder exercising this Warrant) within
the time period required to settle any trade made by the holder after exercise of this Warrant.

     3. Stock Fully Paid; Reservation of Shares. All Shares that may be issued upon the
exercise of the rights represented by this Warrant will, upon issuance pursuant to the terms and
conditions herein, be fully paid and nonassessable, and free from all preemptive rights and taxes,
liens and charges with respect to the issue thereof. During the period within which the rights
represented by this Warrant may be exercised, the Company will at all times have authorized, and
reserved for the purpose of the issue upon exercise of the purchase rights evidenced by this
Warrant, a sufficient number of shares of its Series Preferred to provide for the exercise of the
rights represented by this Warrant and a sufficient number of shares of its Common Stock to provide
for the conversion of the Series Preferred into Common Stock.

     4. Adjustment of Warrant Price and Number of Shares. The number and kind of
securities purchasable upon the exercise of this Warrant and the Warrant Price shall be subject to
adjustment from time to time upon the occurrence of certain events, as follows:

     (a) Reclassification. In case of any reclassification or change of securities of the
class issuable upon exercise of this Warrant (other than a change in par value, or from par value
to no par value, or from no par value to par value, or as a result of a subdivision or
combination), the Company, shall duly execute and deliver to the holder of this Warrant a new
Warrant, so that the holder of this Warrant shall have the right to receive upon exercise of this
Warrant, at a total purchase price not to exceed that payable upon the exercise of the unexercised
portion of this Warrant, and in lieu of the shares of Series Preferred theretofore issuable upon

-2-

 

exercise of this Warrant, the kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification by a holder of the number of shares of Series
Preferred then purchasable under this Warrant. Any new Warrant shall provide for adjustments that
shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section
4. The provisions of this Section 4(a) shall similarly apply to successive reclassifications or
changes.

          (b) Subdivision or Combination of Shares. If the Company at any time while this
Warrant remains outstanding and unexpired shall subdivide or combine its outstanding shares of
Series Preferred, the Warrant Price shall be proportionately decreased and the number of Shares
issuable hereunder shall be proportionately increased in the case of a subdivision and the Warrant
Price shall be proportionately increased and the number of Shares issuable hereunder shall be
proportionately decreased in the case of a combination.

          (c) Stock Dividends and Other Distributions. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend with respect to Series Preferred payable
in Series Preferred, then, upon exercise of this Warrant, for each Share acquired, the holder
hereof shall receive, without cost to the holder hereof, the total number and kind of securities to
which the holder hereof would have been entitled had the holder hereof owned the Shares of record
as of the date the dividend occurred; provided that the holder hereof shall not be entitled
to receive any such securities to the extent that the conversion price of the Shares is
appropriately adjusted to provide for such issuance or distribution upon the conversion of the
Shares.

          (d) Repurchase on Sale, Merger, or Consolidation of the Company.

               (i) Acquisition. For the purpose of this Warrant, “Acquisition” means (a) any sale,
license, or other disposition of all or substantially all of the assets (including intellectual
property) of the Company, (b) any sale or disposition of all or substantially all of the capital
stock of the Company, or (c) any reorganization, consolidation, merger or sale of the voting
securities of the Company or any other transaction, other than a financing transaction, where the
holders of the Company’s securities before the transaction beneficially own less than 50% of the
outstanding voting securities of the surviving entity after the transaction.

               (ii) Assumption of Warrant. If upon the closing of any Acquisition the successor
entity assumes the obligations of this Warrant, then this Warrant shall be exercisable for the same
securities, cash, and property as would be payable for the Shares issuable upon exercise of the
unexercised portion of this Warrant as if such Shares were outstanding on the record date for the
Acquisition and subsequent closing. In the event of an Acquisition in which the outstanding capital
stock of the Company is acquired for shares or stock in a privately held company, the successor
entity shall assume the obligations of this Warrant, and the Warrant shall be exercisable for the
same securities, cash, and property as would be payable for the Shares issuable upon exercise of
the unexercised portion of this Warrant as if such Shares were outstanding on the record date for
the Acquisition and subsequent closing, and the Warrant Price shall be adjusted accordingly. In the
event of an Acquisition in which the outstanding capital stock of the Company is acquired for cash
and/or capital stock of a publicly-traded acquiror, this

-3-

 

Warrant shall be automatically deemed to be exercised and converted pursuant to Section 10.2
below immediately prior to the consummation of the Acquisition.

               (iii) Nonassumption. If upon the closing of any Acquisition the successor entity is
not required to assume the obligations of this Warrant and the holder hereof has not otherwise
exercised this Warrant in full, then this Warrant shall be deemed to have been automatically
converted pursuant to Section 10.2 below and thereafter the holder hereof shall participate in the
Acquisition on the same terms as other holders of the same class of securities of the Company.

          (e) Adjustment of Number of Shares. Upon each adjustment in the Warrant Price, the
number of Shares of Series Preferred purchasable hereunder shall be adjusted, to the nearest whole
share, to the product obtained by multiplying the number of Shares purchasable immediately prior to
such adjustment in the Warrant Price by a fraction, the numerator of which shall be the Warrant
Price immediately prior to such adjustment and the denominator of which shall be the Warrant Price
immediately thereafter.

          (f) Antidilution Rights. The other antidilution rights applicable to the Shares of
Series Preferred purchasable hereunder are set forth in the Company’s Certificate of Incorporation,
as amended and/or restated through the Date of Grant (the “Charter”). Such antidilution rights
shall not be restated, amended, modified or waived in any manner in which the holder is treated
differently than other holders of the same class of securities of the Company without such holder’s
prior written consent. The Company shall promptly provide the holder hereof with any restatement,
amendment, modification or waiver of the Charter promptly after the same has been made.

     5. Notice of Adjustments. Whenever the Warrant Price or the number of Shares
purchasable hereunder shall be adjusted pursuant to Section 4 hereof, the Company shall make a
certificate signed by its chief financial officer setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which such adjustment was
calculated, and the Warrant Price and the number of Shares purchasable hereunder after giving
effect to such adjustment, and shall cause copies of such certificate to be mailed (without regard
to Section 13 hereof, by first class mail, postage prepaid) to the holder of this Warrant. In
addition, whenever the conversion price or conversion ratio of the Series Preferred shall be
adjusted, the Company shall make a certificate signed by its chief financial officer setting forth,
in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method
by which such adjustment was calculated, and the conversion price or ratio of the Series Preferred
after giving effect to such adjustment, and shall cause copies of such certificate to be mailed
(without regard to Section 13 hereof, by first class mail, postage prepaid) to the holder of this
Warrant.

     6. Fractional Shares. No fractional shares of Series Preferred will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares the Company shall
make a cash payment therefor based on the fair market value of the Series Preferred on the date of
exercise as reasonably determined in good faith by the Company’s Board of Directors.

     7. Compliance with Act; Disposition of Warrant or Shares of Series Preferred.

-4-

 

          (a) Compliance with Act. The holder of this Warrant, by acceptance hereof, agrees
that this Warrant, and the shares of Series Preferred to be issued upon exercise hereof and any
Common Stock issued upon conversion thereof are being acquired for investment and that such holder
will not offer, sell or otherwise dispose of this Warrant, or any shares of Series Preferred to be
issued upon exercise hereof or any Common Stock issued upon conversion thereof except under
circumstances which will not result in a violation of the Act or any applicable state securities
laws. Upon exercise of this Warrant, unless the Shares being acquired are registered under the Act
and any applicable state securities laws or an exemption from such registration is available, the
holder hereof shall confirm in writing that the shares of Series Preferred so purchased (and any
shares of Common Stock issued upon conversion thereof) are being acquired for investment and not
with a view toward distribution or resale in violation of the Act and shall confirm such other
matters related thereto as may be reasonably requested by the Company. This Warrant and all shares
of Series Preferred issued upon exercise of this Warrant and all shares of Common Stock issued upon
conversion thereof (unless registered under the Act and any applicable state securities laws) shall
be stamped or imprinted with a legend in substantially the following form:

“THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE
REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY
SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION
LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE
PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED, DIRECTLY OR
INDIRECTLY.”

     Said legend shall be removed by the Company, upon the request of a holder, at such time as the
restrictions on the transfer of the applicable security shall have terminated. In addition, in
connection with the issuance of this Warrant, the holder specifically represents to the Company by
acceptance of this Warrant as follows:

               (1) The holder is aware of the Company’s business affairs and financial condition, and has
acquired information about the Company sufficient to reach an informed and knowledgeable decision
to acquire this Warrant. The holder is acquiring this Warrant for its own account for investment
purposes only and not with a view to, or for the resale in connection with, any “distribution”
thereof in violation of the Act.

               (2) The holder understands that this Warrant has not been registered under the Act in reliance
upon a specific exemption therefrom, which exemption depends upon, among other things, the bona
fide nature of the holder’s investment intent as expressed herein.

               (3) The holder further understands that this Warrant must be held indefinitely unless
subsequently registered under the Act and qualified under any applicable state securities laws, or
unless exemptions from registration and qualification are otherwise available. The holder is aware
of the provisions of Rule 144, promulgated under the Act.

-5-

 

               (4) The holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D
promulgated under the Act.

          (b) Disposition of Warrant or Shares. With respect to any offer, sale or other
disposition of this Warrant or any shares of Series Preferred acquired pursuant to the exercise of
this Warrant prior to registration of such Warrant or shares, the holder hereof agrees to give
written notice to the Company prior thereto, describing briefly the manner thereof, together with a
written opinion of such holder’s counsel, or other evidence, if reasonably satisfactory to the
Company, to the effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect or any federal or state securities
law then in effect) of this Warrant or such shares of Series Preferred or Common Stock and
indicating whether or not under the Act certificates for this Warrant or such shares of Series
Preferred to be sold or otherwise disposed of require any restrictive legend as to applicable
restrictions on transferability in order to ensure compliance with such law. Upon receiving such
written notice and reasonably satisfactory opinion or other evidence, the Company, as promptly as
practicable but no later than fifteen (15) days after receipt of the written notice, shall notify
such holder that such holder may sell or otherwise dispose of this Warrant or such shares of Series
Preferred or Common Stock, all in accordance with the terms of the notice delivered to the Company.
If a determination has been made pursuant to this Section 7(b) that the opinion of counsel for the
holder or other evidence is not reasonably satisfactory to the Company, the Company shall so notify
the holder promptly with details thereof after such determination has been made. Notwithstanding
the foregoing, this Warrant or such shares of Series Preferred or Common Stock may, as to such
federal laws, be offered, sold or otherwise disposed of in accordance with Rule 144 or 144A under
the Act, provided that the Company shall have been furnished with such information as the Company
may reasonably request to provide a reasonable assurance that the provisions of Rule 144 or 144A
have been satisfied. Each certificate representing this Warrant or the shares of Series Preferred
thus transferred (except a transfer pursuant to Rule 144 or 144A) shall bear a legend as to the
applicable restrictions on transferability in order to ensure compliance with such laws, unless in
the aforesaid opinion of counsel for the holder, such legend is not required in order to ensure
compliance with such laws. The Company may issue stop transfer instructions to its transfer agent
in connection with such restrictions.

          (c) Applicability of Restrictions. Neither any restrictions of any legend described in
this Warrant nor the requirements of Section 7(b) above shall apply to any transfer of, or grant of
a security interest in, this Warrant (or the Series Preferred or Common Stock obtainable upon
exercise thereof) or any part hereof (i) to a partner of the holder if the holder is a partnership
or to a member of the holder if the holder is a limited liability company, (ii) to a partnership of
which the holder is a partner or to a limited liability company of which the holder is a member,
(iii) to any affiliate of the holder if the holder is a corporation, (iv) notwithstanding the
foregoing, to any corporation, company, limited liability company, limited partnership,
partnership, or other person managed or sponsored by Compass Horizon Funding Company LLC (“Finance
LLC”) or its principals or in which Finance LLC has an interest, (v) to Horizon Credit I LLC or
(vi) to a lender to the holder or any of the foregoing; provided, however, in any
such transfer, if applicable, the transferee shall on the Company’s request agree in writing to be
bound by the terms of this Warrant as if an original holder hereof. Notwithstanding any term or
condition contained in this Warrant to the contrary, the Company may refuse to transfer this

-6-

 

Warrant or issue shares issuable upon conversion or exercise of this Warrant to any person
(whether legal or natural) who is reasonably determined in good faith by the Company’s Board of
Directors to be an actual or potential competitor of the Company (or who is an affiliate of any
person (whether legal or natural) so deemed to be an actual or potential competitor of the
Company).

     8. Rights as Shareholders; Information. No holder of this Warrant, as such, shall be
entitled to vote or receive dividends or be deemed the holder of Series Preferred or any other
securities of the Company which may at any time be issuable upon the exercise hereof for any
purpose, nor shall anything contained herein be construed to confer upon the holder of this
Warrant, as such, any of the rights of a shareholder of the Company or any right to vote for the
election of directors or upon any matter submitted to shareholders at any meeting thereof, or to
receive notice of meetings, or to receive dividends or subscription rights or otherwise until this
Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have
become deliverable, as provided herein. Notwithstanding the foregoing, until the closing of the
IPO, the Company will transmit to the holder of this Warrant such information, documents and
reports as are generally distributed to the holders of any class or series of the securities of the
Company concurrently with the distribution thereof to the shareholders.

     9. Registration Rights. The Company grants registration rights to the holder of this
Warrant for any Common Stock of the Company obtained upon conversion of the Series Preferred,
comparable to the registration rights granted to Square 1 Bank in that certain Fifth Amended and
Restated Stockholders Rights Agreement dated as of October 15, 2008, as amended (the “Stockholder
Rights Agreement”).

     10. Additional Rights.

     10.1 Acquisition Transactions. The Company shall provide the holder of this Warrant
with at least ten (10) days’ written notice prior to closing thereof of the terms and conditions of
any Acquisition.

     10.2 Right to Convert Warrant into Stock: Net Issuance.

          (a) Right to Convert. In addition to and without limiting the rights of the holder
under the terms of this Warrant, the holder shall have the right to convert this Warrant or any
portion thereof (the “Conversion Right”) into shares of Series Preferred as provided in this
Section 10.2 at any time or from time to time during the term of this Warrant. Upon exercise of the
Conversion Right with respect to a particular number of shares subject to this Warrant (the
“Converted Warrant Shares”), the Company shall deliver to the holder (without payment by the holder
of any exercise price or any cash or other consideration) that number of shares of fully paid and
nonassessable Series Preferred as is determined according to the following formula:

	 	 	 	 	 	 	 
	 

	 	X=
	 	B - A
 

Y
	 	 

	 	 	 
	       Where: X =

	 	the number of shares of Series Preferred that shall be issued to holder
	 
	 	 
	Y =

	 	the fair market value of one share of Series Preferred

-7-

 

	 	 	 
	A =

	 	the aggregate Warrant Price of the specified number of
Converted Warrant Shares immediately prior to the exercise of the Conversion
Right (i.e., the number of Converted Warrant Shares multiplied by the Warrant
Price)
	 
	 	 
	B =

	 	the aggregate fair market value of the specified number of
Converted Warrant Shares (i.e., the number of Converted Warrant Shares
multiplied by the fair market value of one Converted Warrant Share)

     No fractional shares shall be issuable upon exercise of the Conversion Right, and, if the
number of shares to be issued determined in accordance with the foregoing formula is other than a
whole number, the Company shall pay to the holder an amount in cash equal to the fair market value
of the resulting fractional share on the Conversion Date (as hereinafter defined). For purposes of
Section 10 of this Warrant, shares issued pursuant to the Conversion Right shall be treated as if
they were issued upon the exercise of this Warrant.

          (b) Method of Exercise. The Conversion Right may be exercised by the holder by the
surrender of this Warrant at the principal office of the Company together with a written statement
(which may be in the form of Exhibit A-1 or Exhibit A-2 hereto) specifying that the holder thereby
intends to exercise the Conversion Right and indicating the number of shares subject to this
Warrant which are being surrendered (referred to in Section 10.2(a) hereof as the Converted Warrant
Shares) in exercise of the Conversion Right. Such conversion shall be effective upon receipt by the
Company of this Warrant together with the aforesaid written statement, or on such later date as is
specified therein (the “Conversion Date”), and, at the election of the holder hereof, may be made
contingent upon the closing of the sale of the Company’s Common Stock to the public in a public
offering pursuant to a Registration Statement under the Act (a “Public Offering”). Certificates for
the shares issuable upon exercise of the Conversion Right and, if applicable, a new warrant
evidencing the balance of the shares remaining subject to this Warrant, shall be issued as of the
Conversion Date and shall be delivered to the holder within thirty (30) days following the
Conversion Date.

          (c) Determination of Fair Market Value. For purposes of this Section 10.2, “fair
market value” of a share of Series Preferred (or Common Stock if the Series Preferred has been
automatically converted into Common Stock) as of a particular date (the “Determination Date”) shall
mean:

               (i) If the Conversion Right is exercised in connection with and contingent upon a Public
Offering, and if the Company’s Registration Statement relating to such Public Offering
(“Registration Statement”) has been declared effective by the Securities and Exchange Commission,
then the initial “Price to Public” specified in the final prospectus with respect to such offering,
net of any discounts and/or commissions paid to the underwriters.

               (ii) If the Conversion Right is not exercised in connection with and contingent upon a Public
Offering, then as follows:

          (A) If traded on a securities exchange, the fair market value of the Common Stock shall be
deemed to be the average of the closing prices of the Common Stock on such exchange over the five
trading days immediately prior to the Determination Date, and the fair

-8-

 

market value of the Series Preferred shall be deemed to be such fair market value of the
Common Stock multiplied by the number of shares of Common Stock into which each share of Series
Preferred is then convertible;

          (B) If traded on the Nasdaq Stock Market or other over-the-counter system, the fair market
value of the Common Stock shall be deemed to be the average of the closing bid prices of the Common
Stock over the five trading days immediately prior to the Determination Date, and the fair market
value of the Series Preferred shall be deemed to be such fair market value of the Common Stock
multiplied by the number of shares of Common Stock into which each share of Series Preferred is
then convertible; and

          (C) If there is no public market for the Common Stock, then fair market value shall be
determined by the Board of Directors of the Company in good faith.

In making a determination under clauses (A) or (B) above, if on the Determination Date, five
trading days had not passed since the IPO, then the fair market value of the Common Stock shall be
the average closing prices or closing bid prices, as applicable, for the shorter period beginning
on and including the date of the IPO and ending on the trading day prior to the Determination Date
(or if such period includes only one trading day, the closing price or closing bid price, as
applicable, for such trading day). If closing prices or closing bid prices are no longer reported
by a securities exchange or other trading system, the closing price or closing bid price shall be
that which is reported by such securities exchange or other trading system at 4:00 p.m. New York
City time on the applicable trading day.

     10.3 Exercise Prior to Expiration. To the extent this Warrant is not previously
exercised as to all of the Shares subject hereto, and if the fair market value of one share of the
Series Preferred is greater than the Warrant Price then in effect, this Warrant shall be deemed
automatically exercised pursuant to Section 10.2 above (even if not surrendered) immediately before
its expiration. For purposes of such automatic exercise, the fair market value of one share of the
Series Preferred upon such expiration shall be determined pursuant to Section 10.2(c). To the
extent this Warrant or any portion thereof is deemed automatically exercised pursuant to this
Section 10.3, the Company agrees to promptly notify the holder hereof of the number of Shares, if
any, the holder hereof is to receive by reason of such automatic exercise.

     11. Representations and Warranties. The Company represents and warrants to the holder
of this Warrant as follows:

          (a) This Warrant has been duly authorized and executed by the Company and is a valid and
binding obligation of the Company enforceable in accordance with its terms, subject to laws of
general application relating to bankruptcy, insolvency and the relief of debtors and the rules of
law or principles at equity governing specific performance, injunctive relief and other equitable
remedies.

          (b) The Shares have been duly authorized and reserved for issuance by the Company and, when
issued in accordance with the terms hereof, will be validly issued, fully paid and nonassessable
and free from preemptive rights.

-9-

 

          (c) The rights, preferences, privileges and restrictions granted to or imposed upon the Series
Preferred and the holders thereof are as set forth in the Charter, and on the Date of Grant, each
share of the Series Preferred represented by this Warrant is convertible into one share of Common
Stock.

          (d) The shares of Common Stock issuable upon conversion of the Shares have been duly
authorized and reserved for issuance by the Company and, when issued in accordance with the terms
of the Charter will be validly issued, fully paid and nonassessable.

          (e) Assuming the accuracy of the representations of the holder hereof in Section 7(a) above,
the execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of
this Warrant in accordance with the terms hereof will not be, inconsistent with the Company’s
Charter or by-laws, do not and will not contravene any law, governmental rule or regulation,
judgment or order applicable to the Company, and do not and will not conflict with or contravene
any provision of, or constitute a default under, any indenture, mortgage, contract or other
instrument of which the Company is a party or by which it is bound or require the consent or
approval of, the giving of notice to, the registration or filing with or the taking of any action
in respect of or by, any Federal, state or local government authority or agency or other person,
except for the filing of notices pursuant to federal and state securities laws, which filings, if
any, will be effected by the time required thereby.

          (f) There are no actions, suits, audits, investigations or proceedings pending or, to the
knowledge of the Company, threatened against the Company in any court or before any governmental
commission, board or authority which, if adversely determined, could have a material adverse effect
on the ability of the Company to perform its obligations under this Warrant.

          (g) The number of shares of Common Stock of the Company outstanding on the date hereof, on a
fully diluted basis (assuming the conversion of all outstanding convertible securities and the
exercise of all outstanding options and warrants), does not exceed 37,000,000 shares.

     12. Modification and Waiver. This Warrant and any provision hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the party against which
enforcement of the same is sought.

     13. Notices. Any notice, request, communication or other document required or
permitted to be given or delivered to the holder hereof or the Company shall be delivered, or shall
be sent by certified or registered mail, postage prepaid, to each such holder at its address as
shown on the books of the Company or to the Company at the address indicated therefor on the
signature page of this Warrant.

     14. Lost Warrants or Stock Certificates. The Company covenants to the holder hereof
that, upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant or any stock certificate and, in the case of any such
loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company, or
in the case of any such mutilation upon surrender and cancellation of such Warrant or stock

-10-

 

certificate, the Company will make and deliver a new Warrant or stock certificate, of like
tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate.

     15. Descriptive Headings. The descriptive headings of the various Sections of this
Warrant are inserted for convenience only and do not constitute a part of this Warrant. The
language in this Warrant shall be construed as to its fair meaning without regard to which party
drafted this Warrant.

     16. Governing Law. This Warrant shall be construed and enforced in accordance with,
and the rights of the parties shall be governed by, the laws of the State of Delaware.

     17. Survival of Representations, Warranties and Agreements. All representations and
warranties of the Company and the holder hereof contained herein shall survive the Date of Grant,
the exercise or conversion of this Warrant (or any part hereof) or the termination or expiration of
rights hereunder. All agreements of the Company and the holder hereof contained herein shall
survive indefinitely until, by their respective terms, they are no longer operative.

     18. Remedies. In case any one or more of the covenants and agreements contained in
this Warrant shall have been breached, the holders hereof (in the case of a breach by the Company),
or the Company (in the case of a breach by a holder), may proceed to protect and enforce their or
its rights either by suit in equity and/or by action at law, including, but not limited to, an
action for damages as a result of any such breach and/or an action for specific performance of any
such covenant or agreement contained in this Warrant.

     19. No Impairment of Rights. The Company will not, by amendment of its Charter or
through any other means, avoid or seek to avoid the observance or performance of any of the terms
of this Warrant, but will at all times in good faith assist in the carrying out of all such terms
and in the taking of all such action as may be necessary or appropriate in order to protect the
rights of the holder of this Warrant against impairment.

     20. Severability. The invalidity or unenforceability of any provision of this Warrant
in any jurisdiction shall not affect the validity or enforceability of such provision in any other
jurisdiction, or affect any other provision of this Warrant, which shall remain in full force and
effect.

     21. Recovery of Litigation Costs. If any legal action or other proceeding is brought
for the enforcement of this Warrant, or because of an alleged dispute, breach, default, or
misrepresentation in connection with any of the provisions of this Warrant, the successful or
prevailing party or parties shall be entitled to recover reasonable attorneys’ fees and other costs
incurred in that action or proceeding, in addition to any other relief to which it or they may be
entitled.

     22. Entire Agreement; Modification. This Warrant constitutes the entire agreement
between the parties pertaining to the subject matter contained in it and supersedes all prior and
contemporaneous agreements, representations, and undertakings of the parties, whether oral or
written, with respect to such subject matter.

-11-

 

     23. “Market Stand-off’ Agreement. The holder hereof hereby agrees that it will not,
without the prior written consent of the managing underwriter in an initial public offering of the
Company, during the period commencing on the date of the final prospectus relating to such initial
public offering and ending on the date specified by the Company and the managing underwriter (such
period not to exceed one hundred eighty (180) days or such longer period as is necessary to
facilitate compliance with NASD Rule 2711 or NYSE Member Rule 472 or any successor or similar rule
or regulation), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to
purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase;
or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for Common Stock held immediately before
the effective date of the registration statement for such offering or (ii) enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii)
above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The
foregoing provisions of this Section 23 shall apply only to an initial public offering of the
Company, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting
agreement, and shall be applicable to the holder hereof only if all officers, directors, and
stockholders individually owning more than one percent (1%) of the Company’s outstanding Common
Stock are subject to the same restrictions. The underwriters in connection with an initial public
offering of the Company are intended third-party beneficiaries of this Section 23 and shall have
the right, power, and authority to enforce the provisions hereof as though they were a party
hereto. The holder hereof further agrees to execute such agreements as may be reasonably requested
by the underwriters an the initial public offering of the Company that are consistent with this
Section 23 or that are necessary to give further effect thereto. Any discretionary waiver or
termination of the restrictions of any or all of such agreements by the Company or the underwriters
shall apply pro rata to all holders subject to such agreements.

[Remainder of page intentionally left blank.]

-12-

 

     The Company has caused this Warrant to be duly executed and delivered as of the Date of Grant
specified above.

	 	 	 	 	 	 	 
	 	 	WATERFRONT MEDIA INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Alan Shapiro
 

Alan Shapiro
	 	 
	 

	 	Title:
	 	Senior Vice President and General Counsel	 	 

	 	 	 	 	 	 	 
	 

	 	Address:
	 	45 Main Street
	 	 
	 

	 	 	 	Brooklyn, New York 11201	 	 

-13-exv10w1

Exhibit 10.1

AGORA MEDIA INC.

2003 STOCK OPTION PLAN, AS AMENDED

     1. Purpose. Agora Media Inc., a Delaware corporation (“Agora”), desires to attract
and retain the best available talent and to encourage the highest level of performance. The Agora
Media Inc. 2003 Stock Option Plan, as amended (the “Plan”), is intended to contribute
significantly to the attainment of these objectives by affording eligible employees and independent
contractors of Agora and its affiliates (whether or not incorporated) (collectively, with Agora,
the “Company”) the opportunity to acquire a proprietary interest in Agora through the grant
of stock options (“Options”) to purchase shares of common stock, $.01 par value per share,
of Agora (the “Common Stock”).

     2. Administration.

          (a) In General. Subject to paragraph (b) hereof, the Plan shall be administered by
the board of directors of Agora (the “Board”). The Board shall have plenary authority in
its discretion, to the maximum extent permissible by law, subject to and not inconsistent with the
express provisions of the Plan, to make all awards of Options under the Plan, to select from among
eligible persons those individuals who will be awarded Options, to determine the number of shares
of Common Stock covered by each Option, the Option exercise price per share of Common Stock covered
by each Option (and, in connection therewith, determine the Fair Market Value of the Common Stock
for purposes of the Plan), and the restrictions, if any, which shall apply to the Common Stock
subject to an Option, to determine the terms and conditions of each Option, to approve the form of
each Option agreement (an “Option Agreement”), to amend any such Option Agreement from time
to time, to construe and interpret the Plan and all Option Agreements executed thereunder and to
make all other determinations necessary or advisable for the administration of the Plan. In
exercising its authority to set the terms and conditions of Options, and subject only to the limits
of applicable law, the Board shall be under no obligation or duty to treat similarly situated
grantees of an Option Agreement (“Optionees”) in the same manner, and any action taken by
the Board with respect to the grant of an Option to one Optionee shall in no way obligate the Board
to take the same or similar action with respect to any other Optionee. The Board may exercise its
discretion in a manner such that Options which are granted to individuals who are foreign nationals
or who are employed or provide services outside the United States, contain terms and conditions
which are different from the provisions otherwise specified in the Plan but which are consistent
with the tax and other laws of foreign jurisdictions applicable to the Optionee and which are
designed to provide the Optionee with benefits which are consistent with the Company’s objectives
in establishing the Plan. The Board may adopt such rules as it deems necessary or advisable in
order to carry out the purpose of the Plan. All questions of interpretation, administration and
application of the Plan shall be determined by a majority of the members of the Board then in
office, except that the Board may authorize any one or more of its members, or any officer of the
Company, to execute and deliver documents

 

 

(including any applicable Option Agreement) on behalf of the Board or Agora. Any
interpretation or determination made by the Board pursuant to the foregoing shall be conclusive and
binding upon any person having or claiming any interest under the Plan.

          (b) Appointment of Committee. Notwithstanding paragraph (a), the Board may appoint a
committee of not fewer than two members of the Board (the “Committee”) and transfer to the
Committee some or all of its authority hereunder. If the Board creates a Committee, the Board may
from time to time appoint members of the Committee in substitution for or in addition to members
previously appointed and may fill vacancies, however caused, in the Committee. If and when the
Common Stock is registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
“Act”), to the extent necessary to comply with Rule
16b-3 under the Act with respect to Option grants to officers and directors, each member of
the Committee shall be a “non-employee director” within the meaning of Rule 16b-3 and, to the
extent necessary to exclude Options granted under the Plan from the calculation of the income tax
deduction limit under Section 162(m) of the Internal Revenue Code of 1986, as amended (the
“Code”), each member of the Committee shall be an “outside director” within the meaning of
Code Section 162(m). To the extent necessary to be consistent with the provisions of this
paragraph (b), any reference in the Plan and/or an Option Agreement to a decision, determination or
action of the Board shall be read and understood as referring to a decision, determination or
action of the Committee.

          (c) Liability of Board and Committee Members. Except as otherwise required by law, no
member of the Board or the Committee shall be liable for anything whatsoever in connection with the
administration of the Plan other than such member’s own willful misconduct. Under no circumstances
shall any member of the Board or the Committee be liable for any act or omission of any other
member of the Board or the Committee. In the performance of its functions with respect to the
Plan, the Board and the Committee shall be entitled to rely upon information and advice furnished
by Agora’s officers, Agora’s accountants, Agora’s legal counsel and any other party the Board and
Committee deems necessary, and no member of the Board or Committee shall be liable for any action
taken or not taken in reliance upon any such advice.

     3. Type of Options. Options granted under the Plan may be either incentive stock
options (“ISOs”) intended to meet the requirements of Code Section 422 or nonqualified
stock options (“NSOs”) which are not intended to meet such Code requirements.

     4. Eligible Persons. Subject in the case of ISOs to Section 17(a), Options may be
awarded only to officers, employees and independent contractors of the Company. For purposes
hereof, the term “independent contractors” shall include consultants, advisors and directors of the
Company. In determining the persons to whom awards shall be made and the number of shares to be
covered by each Option, the Board shall take into account the duties of the respective persons,
their present and potential contributions to the success of the Company and such other factors as
the Board, in its discretion, shall deem relevant in connection with accomplishing the purposes of
the Plan.

     5. Shares Subject to the Plan. No more than Five Million Seven Hundred Thousand
(5,700,000) shares of Common Stock shall be issued pursuant to the exercise of Options granted
under the Plan. Such aggregate number shall be subject to adjustment as provided in Section 16.
If an Option is forfeited or expires without being exercised, the shares of Common Stock subject

2

 

to the Option shall be available for additional Option grants under the Plan. If an Option is
exercised in whole or in part by an Optionee by tendering previously owned shares of Common Stock,
or if any shares are withheld in connection with the exercise of its Option to satisfy the
Optionee’s tax liability, the full number of shares in respect of which the Option has been
exercised shall be applied against the limit set forth in this Section 5.

     6. Term of Options. The term of each Option shall be fixed by the Board and specified
in the applicable Option Agreement, but in no event shall it be more than ten years from the date
of grant, subject to earlier termination as provided in Section 8. Subject in the case of ISOs to
Section 17, the term of an Option may be extended from time to time by the Board, provided that no
such extension shall extend the term beyond ten years from the date of grant.

     7. Vesting. The Board shall determine the vesting schedule applicable to a particular
Option grant and specify the vesting schedule in the applicable Option Agreement. Notwithstanding
the foregoing the Board may accelerate the vesting of an Option at any time.

     8. Termination of Relationship to the Company.

          (a) Options Granted To Employees. With respect to an Option granted to an individual
who is an employee of the Company at the time of Option grant, unless the Option Agreement
expressly provides to the contrary, (i) the Option shall terminate immediately upon the Optionee’s
termination of employment for Cause (as defined in Section 23); (ii) in the event that the
Optionee’s employment with the Company shall terminate by reason of death or Disability (as
hereinafter defined), the unvested portion of the Option shall terminate immediately and the vested
portion of the Option shall terminate one year following such termination of employment (but shall
not continue to vest during such one year period); and (iii) in the event that the Optionee’s
employment with the Company shall terminate for any other reason, the unvested portion of the
Option shall terminate immediately and the vested portion of the Option shall terminate three
months after such termination of employment (but shall not continue to vest during such three month
period); provided, however, that in the event that the Optionee is subject to any non-compete or
confidentiality agreement which he or she violates, the Option shall immediately terminate upon
such violation. Notwithstanding anything herein to the contrary, in no event shall an Option
remain exercisable beyond the expiration date specified in the applicable Option Agreement. An
Option Agreement may contain such provisions as the Board shall approve with reference to the
determination of the date employment terminates for purposes of the Plan and the effect of leaves
of absence, which provisions may vary from one Option Agreement to another. For purposes hereof,
the Optionee shall be deemed to have a “Disability” if the Optionee is permanently and totally
disabled, within the meaning of Section 22(e) of the Code.

          (b) Options Granted to Independent Contractors. With respect to an Option granted to
an individual who is not an employee of the Company at the time of Option grant, the Board shall
determine and specify in the applicable Option Agreement the consequences, if any, of the
termination of the Optionee’s relationship with the Company.

     9. Option Exercise Price. Subject in the case of ISOs to Section 17, the Option
exercise price per share of Common Stock covered by an Option shall be established by the Board.

     10. Exercise of Options.

3

 

          (a) An Option may be exercised at any time and from time to time, in whole or in part, as to
any or all full shares as to which the Option is then exercisable; provided, however, that if so
specified in the Option Agreement, the Option may not, in a single exercise, be exercised for fewer
than the minimum number of shares specified in the Option Agreement, unless the exercise is for all
of the shares as to which the Option is then exercisable. An Option may not be exercised with
respect to a fractional share. If an Option is exercised with respect to all of the whole shares
as to which the Option is exercisable, and the Option remains exercisable with respect to less than
one share of Common Stock, the Option shall immediately and without any further action by the
Company or the Optionee be cancelled with respect to the remaining fractional share, without any
consideration being paid by the Company. An Optionee (or other person who, pursuant to Section 13,
may exercise the Option) shall exercise the Option by delivering to Agora at the address provided
in the Option Agreement a written, signed notice of exercise, stating the number of shares of
Common Stock with respect to which the option exercise is being made, and satisfy the requirements
of paragraph (b) of this Section 10. Upon receipt by Agora of any notice of exercise, the exercise
of the Option as set forth in that notice shall be irrevocable.

          (b) Upon exercise of an Option the Optionee shall pay to Agora the Option exercise price per
share of Common Stock multiplied by the number of full shares as to which the Option is then
exercised. An Optionee may pay the Option exercise price by tendering or causing to be tendered in
cash, by delivery of shares of Common Stock owned by the Optionee for at least six months preceding
the date of exercise of the Option (or such shorter or longer period as the Board may approve or
require from time to time) having a Fair Market Value equal to the exercise price or other property
permitted by law and acceptable to the Board, or any combination thereof. Without limiting the
foregoing, after the Common Stock becomes Publicly Traded (as defined in Section 23), payment of
the exercise price may be facilitated by an outside broker.

          (c) An Optionee shall, upon notification of the amount due and prior to or concurrently with
delivery of the certificate representing the shares as to which the Option has been exercised,
promptly pay or cause to be paid the amount determined by the Board as necessary to satisfy all
applicable tax and other withholding requirements. An Optionee may satisfy his withholding
requirement in any manner satisfactory to the Board.

          (d) If at the time of Option exercise (i) the Common Stock is not Publicly Traded and (ii) the
Optionee is so requested by Agora, prior to or concurrently with delivery of the certificate
representing the shares as to which the Option has been exercised, the Optionee shall become a
party to a stockholders agreement between stockholders of Agora and Agora.

          (e) The certificate representing the shares as to which an Option has been exercised shall
bear an appropriate legend setting forth the restrictions applicable to such shares.

     11. Option Agreement. The terms and conditions of each Option shall be set forth in
an Option Agreement in the form approved by the Board. Each Option Agreement shall be executed by
Agora and the Optionee. Each Option Agreement shall, at a minimum, specify (i) the number of
shares of Common Stock subject to the Option, (ii) whether the Option is intended to be an ISO or
NSO, (iii) the provisions related to vesting and exercisability of the Option, including the Option
exercise price, and (iv) that the Option is subject to the terms and provisions of the Plan and
that in the event of any conflict between the Option Agreement and

4

 

the Plan, the Plan shall control. The Option Agreement may also contain such other terms and
conditions as the Board determines to be necessary or advisable. Option Agreements may vary from
one to another.

     12. No Stockholder Rights. No Optionee shall have the rights of a stockholder with
respect to shares covered by an Option until such person becomes the holder of record of such
shares. If in connection with an exercise of the Option the Optionee pays all or a portion of the
Option exercise price with shares of Common Stock, the Optionee shall continue to be the
stockholder of record with respect to the shares which he has tendered as exercise payment until
the Optionee becomes the holder of record of the shares of Common Stock to be acquired upon such
exercise.

     13. Nontransferability.

          (a) Subject to paragraphs (b) and (c), Options granted under the Plan shall not be assignable
or transferable other than by will or the laws of descent and distribution and Options may be
exercised during the lifetime of the Optionee only by the Optionee or by the Optionee’s guardian or
legal representative. In the event of any attempt by an Optionee to transfer, assign, pledge,
hypothecate or otherwise dispose of an Option or any right thereunder, except as provided for
herein, or in the event of the levy of any attachment, execution or similar process upon the rights
or interest hereby conferred, Agora may terminate the Option by notice to the Optionee and it shall
thereupon become null and void.

          (b) Notwithstanding paragraph (a), if and only if (and on the terms) so provided in the
applicable Option Agreement, an Optionee may transfer a NSO, by gift or a domestic relations order,
to a Family Member of the Optionee (as defined in Section 23). If a NSO is transferred in
accordance with this subparagraph, the Option shall be exercisable solely by the transferee, but
the determination of the exercisability of the Option shall be based solely on the activities and
state of affairs of the Optionee. Thus, for example, if after a transfer the Optionee ceases to be
an employee of the Company, such termination shall trigger the provisions of Section 8 hereof.
Conversely, if after a transfer the transferee ceases to be an employee of the Company, such
termination shall not trigger the provisions of Section 8 hereof.

          (c) Notwithstanding paragraph (a) an Optionee may transfer an NSO with the express, written
consent of the Board (which consent may be withheld for any reason or for no reason).

     14. Compliance with Law; Registration of Shares.

          (a) The Plan and any grant hereunder shall be subject to all applicable laws, rules, and
regulations of any applicable jurisdiction or authority or agency thereof and to such approvals by
any regulatory or governmental authority or agency or securities exchange which, in the opinion of
Company’s counsel, may be required or appropriate.

          (b) Notwithstanding any other provision of the Plan or Option Agreements made pursuant hereto,
the Company shall not be required to issue or deliver any certificate or certificates for shares of
Common Stock under the Plan prior to fulfillment of all of the following conditions:

               i. Effectiveness of any registration or other qualification of such shares of the Company
under any law or regulation of any applicable jurisdiction or authority or agency

5

 

thereof which the Board shall, in its absolute discretion or upon the advice of counsel, deem
necessary or advisable; and

               ii. Grant of any other consent, approval or permit from any applicable jurisdiction or
authority or agency thereof or securities exchange which the Board shall, in its absolute
discretion or upon the advice of counsel, deem necessary or advisable.

     The Company shall use all reasonable efforts to obtain any consent, approval or permit
described above; provided, however, that except to the extent as may be specifically required in an
Option Agreement with respect to any particular Option grant, the Company shall be under no
obligation to register or qualify any shares subject to an Option under any federal or state
securities law or on any exchange.

     15. No Restriction on the Right of Agora to Effect Corporate Changes. The Plan and
the Options granted hereunder shall not affect in any way the right or power of Agora or its
stockholders to make or authorize any or all adjustments, recapitalization, reorganizations or
other changes in Agora’s or the Company’s capital structure or its business, or any merger or
consolidation of Agora or the Company, or any issue of stock or of options, warrants or rights to
purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are
superior to or affect the Common Stock or the rights of holders thereof or which are convertible
into or exchangeable for Common Stock, or the dissolution or liquidation of Agora or the Company,
or any sale or transfer of all or any part of its assets or business, or any other corporate act or
proceeding, whether of a similar character or otherwise.

     16. Certain Adjustments.

          (a) In the event that Agora or the division, subsidiary or other affiliated entity for which
an Optionee performs services is sold (including a stock or an asset sale), spun off, merged,
consolidated, reorganized or liquidated, the Board may determine that (i) the Option shall be
assumed, or a substantially equivalent Option shall be substituted, by an acquiring or succeeding
entity (or an affiliate thereof) on such terms as the Board determines to be appropriate; (ii)
upon written notice to the Optionee, provide that the Option shall terminate immediately prior to
the consummation of the transaction unless exercised by the Optionee within a specified period
following the date of the notice; (iii) in the event of a sale or similar transaction under the
terms of which holders of Common Stock receive a payment for each share of Common Stock surrendered
in the transaction (the “Sales Price”), make or provide for a payment to each Optionee
equal to the amount by which (A) the Sales Price times the number of shares of Common Stock subject
to the Option (to the extent such Option is then exercisable) exceeds (B) the aggregate exercise
price for all such shares of Common Stock; or (iv) may make such other equitable adjustments as
the Board deems appropriate. Notwithstanding the foregoing, if so specified in an Optionee’s
Option Agreement, if the event described in this paragraph is one in which holders of Common Stock
are to receive stock in the acquiror or an affiliate thereof that is not Publicly Traded, the
Optionee shall be given notice of the transaction and an opportunity prior to the consummation of
the transaction to exercise the Optionee’s vested Option, so that with respect to such vested
Option, the Optionee shall have an opportunity to receive the stock of the acquiror (or its
affiliate) on the same basis as the other holders of Common Stock.

6

 

          (b) In the event of any stock dividend or split, recapitalization, combination, exchange or
similar change affecting the Common Stock, or any other increase or decrease in the number of
issued shares of Common Stock effected without receipt of consideration by the Company, the Board
shall make any or all of the following adjustments as it deems appropriate to equitably reflect
such event: (i) adjust the aggregate number of shares (or such other security as is designated by
the Board) which may be acquired pursuant to the Plan, (ii) adjust the option price to be paid for
any or all such shares subject to the then outstanding Options, (iii) adjust the number of shares
of Common Stock (or such other security as is designated by the Board) subject to any or all of the
then outstanding Options and (iv) make any other equitable adjustments or take such other equitable
action as the Board, in its discretion, shall deem appropriate. For purposes hereof, the
conversion of any convertible securities of the Company shall not be deemed to have been “effected
without receipt of consideration.”

          (c) Any and all adjustments or actions taken by the Board pursuant to this Section shall be
conclusive and binding for all purposes.

     17. ISO Provisions.

          (a) Employment Requirement. ISOs may only be awarded to employees of Agora or a
corporation which, with respect to Agora, is a “parent corporation” or “subsidiary corporation”
within the meaning of Code Sections 424(e) and (f), respectively. Furthermore, except as otherwise
provided in Code Section 422, if an Optionee is no longer employed by Agora or a parent corporation
or subsidiary corporation of Agora, the Optionee’s Option shall cease to be treated as an ISO.

          (b) Option Exercise Price. Subject to paragraph (c), the Option exercise price per
share of Common Stock covered by an ISO shall be no less than the Fair Market Value of a share of
Common Stock on the date of grant of the Option.

          (c) 10% Stockholders. In the case of an individual who at the time the Option is
granted owns stock possessing more than 10% of the total combined voting power of all classes of
the stock of Agora or of a parent or subsidiary corporation of Agora, (i) the Option exercise price
of the Common Stock covered by any ISO granted to such person shall in no event be less than 110%
of the Fair Market Value of the Common Stock on the date the ISO is granted and (ii) the term of an
ISO granted to such person may not exceed five years from the date of grant.

          (d) $100,000 Limit. The aggregate Fair Market Value (determined at the time an ISO is
granted) of the Common Stock covered by ISOs exercisable for the first time by an employee during
any calendar year (under all plans of the Company) may not exceed $100,000.

          (e) Options Which Do Not Satisfy ISO Requirements. To the extent that any Option
which is issued under the Plan exceeds the limit set forth in paragraph (d) or otherwise does not
comply with the requirements of Code Section 422, it shall be treated as a NSO.

     18. No Right to Continued Employment. Neither the Plan nor any action taken hereunder
shall be construed as giving any employee or any independent contractor any right to continue in
the employ of or to be engaged as an independent contractor by the Company or affect the right of
the Company to terminate such person’s employment or other relationship with the Company at any
time.

7

 

     19. Amendment; Early Termination. The Board may at any time and from time to time
alter, amend, suspend or terminate the Plan in whole or in part; provided, however, that no
amendment requiring stockholder approval by law, rules or regulations, or by the rules of any stock
exchange, inter-dealer quotation system, or other market in which shares of Common Stock are
traded, shall be effective unless and until such stockholder approval has been obtained in
compliance with such rule or law; and provided, further, that no such amendment shall materially
adversely affect the rights of an Optionee in any Option previously granted under the Plan without
the Optionee’s written consent.

     20. Effective Date. The Plan shall be effective as of April 1, 2003 (the
“Effective Date”), subject to the approval thereof by the stockholders of Agora entitled to
vote thereon within 12 months of such date. In the event that such stockholder approval is not
obtained within such time period, the Plan and any Options granted under the Plan on or prior to
the expiration of such 12 month period shall be void and of no further force and effect.

     21. Termination of Plan. Unless terminated earlier by the Board in accordance with
Section 19 above, the Plan shall terminate on, and no further Options may be granted after, the
tenth anniversary of the Effective Date.

     22. Severability. In the event that any one or more provisions of the Plan or an
Option Agreement, or any action taken pursuant to the Plan or an Option Agreement, should, for any
reason, be unenforceable or invalid in any respect under the laws of the United States, any state
of the United States or any other jurisdiction, such unenforceability or invalidity shall not
affect any other provision of the Plan or Option Agreement, but in such particular jurisdiction and
instance the Plan and/or Option Agreement, as applicable, shall be construed as if such
unenforceable or invalid provision had not been contained therein or if the action in question had
not been taken thereunder.

     23. Definitions.

          (a) Cause. The term “Cause” when used herein in conjunction with termination of
employment (or other service relationship) means (i) if the Optionee is a party to an employment or
similar agreement with the Company which defines “cause” (or a similar term), the meaning set forth
in such agreement (other than death or Disability), or (ii) otherwise, termination by the Company
of the employment (or other service relationship) of the Optionee by reason of the Optionee’s (1)
intentional failure to perform reasonably assigned duties, (2) dishonesty or willful misconduct in
the performance of his duties, (3) involvement in a transaction which is materially adverse to the
Company, (4) breach of fiduciary duty involving personal profit, (5) willful violation of any law,
rule, regulation or court order (other than misdemeanor traffic violations and misdemeanors not
involving misuse or misappropriation of money or property), (6) commission of an act of fraud or
intentional misappropriation or conversion of any asset or opportunity of the Company, or (7)
material breach of any provision of the Plan, the Optionee’s Option Agreement or any other written
agreement between the Optionee and the Company, in each case as determined in good faith by the
Board, whose determination shall be final, conclusive and binding on all parties.

          (b) Fair Market Value. As used herein, the term “Fair Market Value” means, with
respect to Common Stock on any given date, the closing sales price of the Common Stock for such
date (or, in the event that the Common Stock is not traded on such date, on the immediately
preceding trading date) on the Nasdaq Stock Market or any stock exchange on

8

 

which the Common Stock may be listed, as reported in The Wall Street Journal. If the Common
Stock is not listed on the Nasdaq Stock Market or on a national stock exchange, but is quoted on
the OTC Bulletin Board or by the National Quotation Bureau, the Fair Market Value of the Common
Stock shall be the mean of the bid and asked prices per share of the Common Stock for such date.
If the Common Stock is not quoted or listed as set forth above, Fair Market Value shall be
determined by the Board in good faith by any fair and reasonable means (which means, with respect
to a particular Option grant, may be set forth with greater specificity in the applicable Option
agreement). The Fair Market Value of property other than Common Stock shall be determined by the
Board in good faith by any fair and reasonable means.

          (c) Family Member of the Optionee. As used herein, “Family Member of the Optionee”
means the Optionee’s lineal descendant, stepchild, parent, stepparent, grandparent, spouse, former
spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the
Optionee’s household (other than a tenant or employee), a trust in which the Optionee and/or these
persons have more than 50% of the beneficial interest, a foundation in which these persons (or the
Optionee) control the management of assets, and any other entity in which these persons (or the
Optionee) own more than 50% of the voting interests.

          (d) Publicly Traded. As used herein, Common Stock is “Publicly Traded” if stock of
that class is listed or admitted to unlisted trading privileges on a national securities exchange
or on the Nasdaq National Market or if sales or bid and offer quotations are reported for that
class of stock in the automated quotation system operated by the National Association of Securities
Dealers, Inc.

     24. Transfers to and from Affiliates. For all Plan purposes, a transfer of an
employee from Agora to an Agora affiliate or visa versa, or a transfer from one Agora affiliate to
another, will not be treated as a termination of employment.

     25. Headings. The headings of sections and subsections herein are included solely for
convenience of reference and shall not affect the meaning of any of the provisions of the Plan.

     26. Governing Law. This Plan and all rights hereunder shall be construed in
accordance with and governed by the laws of the State of New York, without regard to any conflict
of law provision that would defer to the substantive laws of another jurisdiction.

9

 

AGORA MEDIA INC.

2003 STOCK OPTION PLAN

NONQUALIFIED STOCK OPTION AGREEMENT

GENERAL PROVISIONS

     THIS AGREEMENT, made as of the Option Grant Date specified in the issuance sheet that is part
of this Nonqualified Stock Option Agreement that is attached hereto (the “Issuance Sheet”, and all
references to this Agreement shall include the Issuance Sheet), by and between Agora Media Inc., a
Delaware corporation (“Agora”), and the officer or employee of Agora or an Agora subsidiary or
affiliate (collectively, the “Company”) identified in the Issuance Sheet (the “Optionee”):

W I T N E S S E T H:

     WHEREAS, Agora has determined to grant stock options to attract and retain the best available
talent and to encourage the highest level of performance, all in accordance with the Agora Media
Inc. 2003 Stock Option Plan (the “Plan”);

     NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants herein contained
and other good and valuable consideration, the parties hereto hereby agree as follows:

     1. Grant of Option. Subject to the terms and conditions of the Plan and this
Agreement, Agora hereby grants to the Optionee the right (the “Option”) to purchase all or any part
of an aggregate of the number of shares of common stock of Agora, par value $.001 per share
(“Common Stock”), specified in the Issuance Sheet.

     2. Vesting Schedule. The Option shall (i) vest (i.e., become exercisable) as to 25%
of all shares of Common Stock subject to the Option on the first anniversary of the Vesting
Commencement Date (as hereinafter defined); and (ii) vest as to the remaining 75% of all shares of
Common Stock subject to the Option on a monthly, pro rata, basis over a three year period
commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth
anniversary of the Vesting Commencement Date, such that the Option shall be vested as to 100% of
all shares of Common Stock subject to the Option on the fourth anniversary of the Vesting
Commencement Date. By way of illustration, the Option shall be vested as to 37.5% of all shares of
Common Stock subject to the Option on the date one and one-half (11/2) years after the Vesting
Commencement Date. The “Vesting Commencement Date” shall be the Option Grant Date, unless a
different date is specified in the Issuance Sheet.

     3. Exercise Price. The price of each share of Common Stock purchased pursuant to this
Option shall be the exercise price specified in the Issuance Sheet.

     4. Manner of Exercise. The Optionee may exercise the Option, in whole or in part,
with respect to any whole number of shares of Common Stock subject to the Option that

 

 

are then vested. The Optionee shall exercise the Option by giving Agora written notice, in a
form prescribed by Agora. Such notice shall specify the number of shares of Common Stock to be
purchased and shall be accompanied by payment, in cash or certified check or by official bank
check, of an amount equal to the Option exercise price per share of Common Stock, multiplied by the
number of shares of Common Stock as to which the Option is being exercised; provided, however, that
the purchase price may be paid by (i) surrender or delivery to Agora of shares of Common Stock
owned by the Optionee for at least six months having a Fair Market Value on the date of exercise
equal to the portion of the purchase price being so paid, or (ii) after the Common Stock becomes
Publicly Traded (as defined in the Plan), by the delivery of funds equal to the purchase price by a
broker, in accordance with Regulation T promulgated by the Board of Governors of the Federal
Reserve System or as otherwise may be permissible by law. The Board may impose from time to time
such limitations as it deems appropriate on the use of shares of Common Stock to exercise the
Option.

     5. Delivery of Common Stock Certificate. Subject to Section 6, as soon as practicable
after receipt of the notice and payment referred to in Section 4 above, Agora shall deliver to the
Optionee (or, in the case of a broker financed exercise described in clause (ii) of Section 4, to
the broker) a certificate or certificates for such shares of Common Stock; provided, however, that
the time of such delivery may be postponed by Agora for such period of time as Agora may require
for compliance with any law, rule or regulation applicable to the issuance or transfer of shares of
Common Stock. The certificate or certificates representing the shares as to which the Option has
been exercised shall bear an appropriate legend setting forth any restrictions applicable to such
shares of Common Stock.

     6. Conditions to Common Stock Issuance. Prior to or concurrently with delivery by
Agora to the Optionee of a certificate(s) representing such shares of Common Stock, the Optionee
shall (i) upon notification of the amount due, promptly pay or cause to be paid, in cash, any
amount necessary to satisfy applicable tax requirements (or otherwise satisfy such withholding
requirements in a manner satisfactory to Agora), and (ii) if the shares of Common Stock are not
then registered under the Securities Act of 1933, as amended (the “Securities Act”) give assurance
satisfactory to Agora that such shares of Common Stock are being purchased for investment (unless
such assurance is not necessary, as determined by Agora) and not with a view to the distribution
thereof other than in compliance with the registration provisions of the Securities Act or any
exemption therefrom, and the Optionee shall give such other assurance and take such other action as
Agora shall require to secure compliance with any law, rule or regulation applicable to the
issuance of shares of Common Stock. Moreover, if at the time of Option exercise the Common Stock
is not Publicly Traded and the Optionee is so requested by the Company, in conjunction with
delivery by the Company of the shares of Common Stock, the Optionee shall enter into a stockholders
agreement by and between stockholders of Agora and Agora Company.

     7. Termination of Option. This Option and all rights of the Optionee to purchase
shares of Common Stock hereunder shall terminate on the tenth anniversary of the Option Grant Date
(the “Expiration Date”), unless terminated earlier in accordance with the terms hereof.

     8. Termination of Employment.

2

 

          (a) Termination of Employment for Cause. In the event that the Company terminates Optionee’s
employment for Cause (as defined in the Plan), the Option shall immediately terminate.

          (b) Death or Disability. In the event that the Optionee’s employment with the Company
terminates by reason of death or Disability (as defined in the Plan), (i) to the extent that
pursuant to Section 2 the Option is not vested on the Optionee’s last day of employment, the Option
shall expire, and (ii) to the extent that it is vested on the Optionee’s last day of employment,
the Option shall continue to be exercisable (but not beyond the Expiration Date) for a period of
one year following such termination.

          (c) Other Termination of Employment. In the event that the Optionee ceases to be an employee
of the Company for any reason other than as described in paragraphs (a) and (b) of this Section 8,
(i) to the extent that pursuant to Section 2 the Option is not vested on the Optionee’s last day of
employment, the Option shall expire, and (ii) to the extent that pursuant to Section 2 the Option
is vested on the Optionee’s last day of employment, the Option shall continue to be exercisable
(but not beyond the Expiration Date) until the date which is three (3) months from Optionee’s last
day of employment; provided, however, that in the event that the Optionee is subject to any
non-compete, non-solicitation or confidentiality agreement which he violates, the Option shall
immediately terminate upon such violation. Solely for purposes of this Section 8, if the Optionee
terminates employment with the Company and immediately thereafter becomes a consultant to the
Company pursuant to a written agreement which so specifies, the Optionee will be deemed to satisfy
the employment requirement of this Section 8 during the period of the Optionee’s consultancy.

     9. Notice. All notices, requests, demands, waivers and communications required or
permitted to be given hereunder shall be in writing and shall be delivered in person or mailed,
certified or registered mail with postage prepaid, or sent by facsimile, as follows:

	 	(a)	 	If to Agora or the Company, to it at:

Agora Media Inc.

45 Main Street, Suite 406

Brooklyn, New York 11201

Attention: Chief Executive Officer.

          (b) If to Optionee, to him or her at the address specified in the Issuance Sheet;

or to such other address as either party hereto shall specify by notice in writing to the other
party in accordance with this Section. In the case of mailing, all such notices, requests,
demands, waivers and communications shall be deemed to have been received on the third business day
after the date of the mailing.

     10. Adjustment. The number of shares of Common Stock subject to the Option and the
price per share of Common Stock shall be subject to adjustment, as set forth in the Plan. Agora
shall not be required to adjust the number of shares of Common Stock subject to

3

 

the Option or the price per share of Common Stock for any reason not specifically enumerated
in the Plan.

     11. No Stockholder Rights. The Optionee shall have no rights as a stockholder of
Agora with respect to shares of Common Stock subject to the Option until payment for such shares
shall have been made in full and until the date of the issuance of stock certificates for such
shares of Common Stock. If the Optionee pays the Option exercise price with shares of Common
Stock, the Optionee shall continue to be the stockholder of record with respect to the shares which
he or she has tendered as exercise payment until the Optionee becomes the holder of record of the
shares covered by the Option.

     12. No Employment Rights. Nothing herein contained shall restrict in any way the
right of the Company to terminate the Optionee’s employment at any time, with or without cause.

     13. Option Subject to Plan. The Optionee acknowledges receipt of a copy of the Plan.
The Option has been granted pursuant to the Plan and is in all respects subject to the terms and
conditions thereof. In the event of any conflict between this Agreement and the Plan, the terms of
the Plan shall control.

     14. Nontransferability.

          (a) Subject to paragraphs (b) and (c), the Option is not transferable, other than by will or
the laws of descent and distribution, and may be exercised, during the lifetime of the Optionee
only by the Optionee, or the Optionee’s guardian or legal representative. In the event of any
attempt by the Optionee to transfer, assign, pledge, hypothecate or otherwise dispose of the Option
or of any right hereunder, except as provided for herein, or in the event of the levy of any
attachment, execution or similar process upon the rights or interest hereby conferred, Agora may
terminate the Option by notice to the Optionee and it shall thereupon become null and void.

          (b) Notwithstanding paragraph (a), the Optionee may transfer the Option, by gift or a domestic
relations order, to a Family Member of the Optionee.

          (c) Notwithstanding paragraph (a) the Optionee may transfer the Option with the express,
written consent of the Board, which consent may be withheld for any reason or for no reason.

     15. Restrictions Applicable to Option Stock.

          (a) Agora’s Right of First Refusal. Before any shares of Common Stock delivered upon Option
exercise (“Shares”) may be transferred, assigned, pledged, hypothecated or otherwise disposed of
(including transfer by gift or operation of law) by the Optionee or any transferee (either being
sometimes referred to in this Section 15 as the “Holder”) (other than pursuant to Section 15(e)),
Agora or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms
and conditions set forth in this Section 15(a) (the “Right of First Refusal”). Pursuant to the
Right of First Refusal, in the event that the Holder of the Shares intends to sell or otherwise
transfer the Shares, the Holder shall be required to deliver to Agora a

4

 

written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or
otherwise transfer such Shares; (ii) the name of each proposed purchaser or other transferee
(“Proposed Transferee”) and the proposed manner of transfer; (iii) the number of Shares to be
transferred to each Proposed Transferee; and (iv) the bona fide cash price or other consideration
for which the Holder proposes to transfer the Shares (the “Offered Price”), and the Holder shall
offer to sell the Shares at the Offered Price to Agora or its assignee(s). At any time within
thirty (30) days after receipt of the Notice, Agora and/or its assignee(s) may, by giving written
notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be
transferred to any one or more of the Proposed Transferees, at the purchase price determined in
accordance with this Section 15(a). The purchase price (“Purchase Price”) for the Shares purchased
by Agora or its assignee(s) under this Section 15(a) shall be the Offered Price. If the Offered
Price includes consideration other than cash, the cash equivalent value of the non-cash
consideration shall be determined by the Board in good faith. Payment of the Purchase Price shall
be made, at the option of Agora or its assignee(s), in cash (by check), by cancellation of all or a
portion of any outstanding indebtedness of the Holder to Agora (or, in the case of repurchase by an
assignee, to the assignee), or by any combination thereof within thirty (30) days after receipt of
the Notice or in the manner and at the times set forth in the Notice. If all of the Shares
proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by Agora
and/or its assignee(s) as provided in this Section 15(a), then the Holder may sell or otherwise
transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price,
provided that such sale or other transfer is consummated within one hundred twenty (120) days after
the date of the Notice and provided further that any such sale or other transfer is effected in
accordance with any applicable securities laws and the Proposed Transferee agrees in writing that
the provisions of Sections 15 and 16 shall continue to apply to the Shares in the hands of such
Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed
Transferee within such period, a new Notice shall be given to Agora, and Agora and/or its assignees
shall again be offered the Right of First Refusal as provided herein before any Shares held by the
Holder may be sold or otherwise transferred. Any attempted transfer which is made in violation of
this paragraph shall be null and void and shall not be honored by Agora.

     Within one hundred twenty (120) days of receipt of the Notice, neither Agora nor the Optionee
may exercise their rights under Section 15(b).

     Anything to the contrary contained in this Section 15(a) notwithstanding, the transfer of any
or all of the Shares during the Optionee’s lifetime or on the Optionee’s death by will or intestacy
to a Family Member of the Optionee (as defined in the Plan) shall be exempt from the provisions of
this Section 15(a). In such case, the transferee or other recipient shall receive and hold the
Shares so transferred subject to the provisions of Sections 15 and 16, and there shall be no
further transfer of such Shares except in accordance with the terms of Sections 15 and 16.

          (b) Agora’s Repurchase Right. At any time after the later of (i) the date Optionee’s
employment with the Company has ended and (ii) the date six months after Optionee has acquired the
Shares, Agora shall have the right to repurchase from the Optionee or any Holder all or any portion
of the Shares pursuant to the terms of this Section 15(b). At the time that Agora exercises its
repurchase right hereunder, Agora shall pay to the Holder in cash

5

 

(or by cancellation of purchase money indebtedness) the Fair Market Value (as defined in the
Plan) of such Shares on such date.

          (c) Purchase of Shares. Any purchase by Agora of Shares and payment therefore pursuant to the
forgoing provisions of this Section 15 shall be against delivery of the certificate representing
the Shares to be purchased by Agora endorsed in blank or together with a stock power executed in
blank.

          (d) No Sales to Competitors. Shares shall not be transferable to competitors of the Company.
For purposes hereof, a person shall be considered to be a “competitor” if at such time it is
engaged in or has under development or is proposed to be engaged in one or more of the businesses
of the Company. The determination of whether a person is a competitor shall be made by the Board
in its sole discretion.

          (e) Drag-Along. If holders in the aggregate of more than 50% of the outstanding shares of
Common Stock of the Company, as one class (“Selling Stockholders”), propose to sell, assign,
mortgage, transfer, pledge, hypothecate or otherwise dispose of all, but not less than all, of
their respective shares to a third party in one or a series of related transactions which is
approved by a majority of the Board, then the Selling Stockholders may, at their option, require
the Holder to sell all of such Holder’s Shares in such transfer to the third party on the same
terms and conditions, and for the same consideration, as the Selling Stockholders. The Holder
shall take such necessary or desirable actions in connection with the consummation of such
transaction as reasonably requested by Agora or the Selling Stockholders.

          (f) Specific Performance. Due to the fact that the Shares cannot be readily purchased or sold
in the open market, and for other reasons, the Company and/or its existing stockholders may be
irreparably damaged in the event that Section 15 of this Agreement is not specifically enforced.
Consequently, in the event of a breach or threatened breach of the terms, covenants and/or
conditions of this Section 15, the Company shall, in addition to all other remedies, be entitled to
a temporary or permanent injunction, without showing any actual damage or posting a bond, and/or a
decree for specific performance, in accordance with the provisions hereof.

          (g) Termination. The restrictions and rights provided for in this Section 15 shall terminate
when the Common Stock becomes Publicly Traded (but shall not result in the acceleration of
installment payments which have commenced pursuant to paragraph (b)).

     16. Lock-Up Agreement. The Optionee agrees that in connection with an underwritten
public offering of Common Stock, upon the request of Agora or the principal underwriter managing
such public offering, shares of Common Stock acquired pursuant to the exercise of the Option (and
any shares of Common Stock received directly or indirectly with respect thereto) may not be sold,
offered for sale or similar financial effect or otherwise disposed of without the prior written
consent of Agora or such underwriter, as the case may be, for a period not exceeding one year after
the effectiveness of the registration statement filed in connection with such offering, but only to
the extent that Agora’s directors, executive officers and/or their immediate family are similarly
bound. The Optionee agrees to sign such further

6

 

documents as Agora may reasonably request to give this Section effect. The lock-up agreement
established pursuant to this Section 16 shall have perpetual duration.

     17. NSO. It is intended that this Option shall not constitute an incentive stock
option for purposes of Section 422 of the Internal Revenue Code of 1986, as amended.

     18. Board Determinations. In the event that any question or controversy shall arise
with respect to the nature, scope or extent of any one or more rights conferred by the Option, or
any provision of this Agreement, the determination by the Board (or the Committee established by
the Board to administer the Plan) of the rights of the Optionee shall be conclusive, final and
binding upon the Optionee and upon any other person who shall assert any right pursuant to this
Option.

     19. Jurisdiction; Venue. Each of Agora and Optionee irrevocably (i) agrees that any
suit, action or proceeding arising out of or relating to this Agreement may be brought in the State
or Federal courts located in The City of New York, County of New York; (ii) consents to the
exclusive jurisdiction of each such court in any suit, action or proceeding relating to or arising
out of this Agreement; (iii) waives any objection which it may have to the laying of venue in any
such suit, action or proceeding in any of such court; and (iv) agrees that service of any court
paper may be made in such manner as may be provided under applicable laws or court rules governing
service of process, including, without limitation, by the mailing of copies thereof by registered
or certified mail, postage pre-paid, to the other party at its address set forth in Section 9
hereof, such service to become effective five (5) business days after such mailing.

     20. Definitions. Any term contained in this Agreement which is defined in the Plan
but not defined herein shall have the meaning provided under the Plan.

     21. Issuance Sheet. The Issuance Sheet attached hereto is hereby incorporated by
reference. The General Provisions and the Issuance Sheet constitute a single Nonqualified Stock
Option Agreement under the Agora Media Inc. 2003 Stock Option Plan.

     22. Replacement of Prior Agreements. Except as otherwise explicitly provided in the
Issuance Sheet, this Agreement sets forth the entire understanding of the parties with respect to
the subject matter provided for herein, including, the grant of stock options and the terms
thereof, and supersedes any and all existing agreements between the parties concerning such subject
matter. The Optionee hereby waives any and all claims that may exist on the date this Agreement is
signed, including, but not limited to, contingent claims, arising from any oral or written
agreement between the parties, including, but not limited to, stock option provisions which may
appear in an employment agreement, which relate to the grant of or the terms of stock options and
all other subject matter provided for herein.

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]